Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilda Mandel

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Israel Medical Association Journal : IMAJ|January 14, 2021
Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood ComponentsMathilda Mandel, Michael Gurevich, Michael Mandelboim, et al.
Plos One|September 28, 2011
Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapyTilda Barliya, Mathilda Mandel, Tami Livnat, et al.
Journal of Clinical Immunology|June 25, 2002
Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiationIlan Bank, Anat Achiron, Gad Levie, et al.
Clinical & Developmental Immunology|November 22, 2005
Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptideMathilda Mandel, Michael Gurevich, Gad Lavie, et al.
European Journal of Internal Medicine|November 7, 2021
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjectsAnat Achiron, Michael Gurevich, Rina Falb, et al.
International Journal of Cancer|July 9, 2004
Antimetastatic activity of the photodynamic agent hypericin in the darkMichael Blank, Gad Lavie, Mathilda Mandel, et al.
Neurobiology of Disease|March 23, 2024
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulationAnat Achiron, Rina Falb, Shay Menascu, et al.
Journal of Neuroimmunology|September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Angiogenesis|September 1, 2005
Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applicationsGad Lavie, Mathilda Mandel, Sadick Hazan, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Israel Medical Association Journal : IMAJ|January 14, 2021
Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood ComponentsMathilda Mandel, Michael Gurevich, Michael Mandelboim, et al.
Plos One|September 28, 2011
Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapyTilda Barliya, Mathilda Mandel, Tami Livnat, et al.
Journal of Clinical Immunology|June 25, 2002
Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiationIlan Bank, Anat Achiron, Gad Levie, et al.
Clinical & Developmental Immunology|November 22, 2005
Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptideMathilda Mandel, Michael Gurevich, Gad Lavie, et al.
European Journal of Internal Medicine|November 7, 2021
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2021
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjectsAnat Achiron, Michael Gurevich, Rina Falb, et al.
International Journal of Cancer|July 9, 2004
Antimetastatic activity of the photodynamic agent hypericin in the darkMichael Blank, Gad Lavie, Mathilda Mandel, et al.
Neurobiology of Disease|March 23, 2024
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulationAnat Achiron, Rina Falb, Shay Menascu, et al.
Journal of Neuroimmunology|September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Angiogenesis|September 1, 2005
Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applicationsGad Lavie, Mathilda Mandel, Sadick Hazan, et al.
Pageof 4